Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Taiki Ando"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract IgG4-related disease (IgG4-RD) was recently described in Japan. It is characterised by extensive organ involvement with tissue fibrosis. We assessed the performance of the 2019 American College of Rheumatology and European League Against Rhe
Externí odkaz:
https://doaj.org/article/e4e33812a5514bd8b9650b53f014c597
Publikováno v:
Modern Rheumatology Case Reports; Jul2024, Vol. 8 Issue 2, p368-372, 5p
Autor:
Ayako Matsumura, Takuya Miyazaki, Takayoshi Tachibana, Taiki Ando, Megumi Koyama, Satoshi Koyama, Yoshimi Ishii, Hiroyuki Takahashi, Yuki Nakajima, Ayumi Numata, Wataru Yamamoto, Kenji Motohashi, Maki Hagihara, Kenji Matsumoto, Shin Fujisawa, Hideaki Nakajima
Publikováno v:
Turkish Journal of Hematology, Vol 37, Iss 1, Pp 20-29 (2020)
Objective: A soluble form of suppression of tumorigenicity 2 (sST2) has emerged as a biomarker for acute graft-versus-host disease (GVHD) and non-relapse mortality (NRM). We prospectively monitored sST2 levels during the early phase of hematopoietic
Externí odkaz:
https://doaj.org/article/4b4bc0a7ebd54f418fa3fe9dadeb5d10
Autor:
Ryu Watanabe, Megumi Oshima, Norihiro Nishioka, Ken-Ei Sada, Kenji Nagasaka, Mitsuhiro Akiyama, Taiki Ando, Tomoaki Higuchi, Yoshino InoueFirst Department of Internal Medicine, School of Medicine,University of Occupational and Environmental Health, Kitakyushu, Japan, Takashi Kida, Tomoyuki Mutoh, Akihiko Nakabayashi, Akira Onishi, Ryota Sakai, Daisuke Waki, Yosuke Yamada, Nobuyuki Yajima, Naoto Tamura, Shinya Kaname, Masayoshi Harigai
Publikováno v:
Modern Rheumatology; Sep2023, Vol. 33 Issue 5, p982-989, 8p
Autor:
Kenji Matsumoto, Shin Fujisawa, Taiki Ando, Megumi Koyama, Satoshi Koyama, Yoshimi Ishii, Ayumi Numata, Wataru Yamamoto, Kenji Motohashi, Maki Hagihara, Hideaki Nakajima
Publikováno v:
Turkish Journal of Hematology, Vol 35, Iss 3, Pp 181-184 (2018)
Objective: Useful prognostic biomarkers for diffuse large B-cell lymphoma (DLBCL) patients have been reported. To determine the prognostic value of hemoglobin (Hb) level in DLBCL patients, we performed a retrospective study. Materials and Methods: We
Externí odkaz:
https://doaj.org/article/61caa6ee9ca54c87b71870e6bdee68b9
Autor:
Yoshiyuki Abe, Masahiro Kogami, Taiki Ando, Ayako Makiyama, Yuko Asanuma, Ken Yamaji, Naoto Tamura
Background This study evaluated the glucocorticoid (GC)-sparing effect of mepolizumab (MEP) in severe eosinophilic granulomatous polyangiitis (EGPA). Methods Participants were patients diagnosed with EGPA according to Watts’ algorithm and who under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9473b393ac1d054fa89c06332ea3eb35
https://doi.org/10.21203/rs.3.rs-2958589/v1
https://doi.org/10.21203/rs.3.rs-2958589/v1
Autor:
Yoshiyuki Abe, Kentaro Minowa, Masahiro Kogami, Taiki Ando, Ayako Makiyama, Ken Yamaji, Naoto Tamura
Publikováno v:
Rheumatology.
Autor:
Ryu Watanabe, Megumi Oshima, Norihiro Nishioka, Ken-Ei Sada, Kenji Nagasaka, Mitsuhiro Akiyama, Taiki Ando, Tomoaki Higuchi, Yoshino Inoue, Takashi Kida, Tomoyuki Mutoh, Akihiko Nakabayashi, Akira Onishi, Ryota Sakai, Daisuke Waki, Yosuke Yamada, Nobuyuki Yajima, Naoto Tamura, Shinya Kaname, Masayoshi Harigai
Publikováno v:
Modern Rheumatology.
Objectives The objective of this study is to provide evidence for the revision of clinical practice guidelines for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis by the Japan Research Committee for Intractable Vasc
Autor:
Yosuke, Takeshita, Marika, Tanaka, Mayoko, Shirafuta, Taiki, Ando, Toshikazu, Gondo, Naoya, Nakamura, Katsumichi, Fujimaki, Shin, Fujisawa, Hideaki, Nakajima
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 63(7)
This study reports two cases of dasatinib-associated lymphadenopathy (DAL). Case 1 involved a 58-year-old man diagnosed with chronic myelogenous leukemia (CML). After 13 months of starting on dasatinib treatment, a molecular response (MR) 4.5 was ach
Publikováno v:
Rheumatology (Oxford, England).
Objectives Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive DM is characterized by rapidly progressive interstitial lung disease and has a poor prognosis. We aimed to investigate whether anti-MDA5 antibody titres and cytokine